Franziska Buescheck (Franziska Büscheck)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 2

Top Topics

Radical Prostatectomy

Nitric Oxide Synthase

Prostate Cancer

Top Venues

Molecular cancer research : MCR

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Elena Bady, Katharina Möller, Tim Mandelkow, Jonas B Raedler, Cheng Yang, Julia Ebner, Magalie C J Lurati, Ronald Simon, Eik Vettorazzi, Franziska Buescheck, Andreas M Luebke, David Dum, Anne Menz, Guido Sauter, Doris Hoeflmayer, Soeren Weidemann, Christoph Fraune, Ria Uhlig, Christian Bernreuther, Frank Jacobsen, Till Sebastian Clauditz, Waldemar Wilczak, Eike C Burandt, Stefan Steurer, Sarah Minner, Maximilian Lennartz, Niclas C Blessin
BLEACH&STAIN 15-marker multiplexed imaging in 3098 human carcinomas reveals 6 major PD-L1-driven immune phenotypes with distinct spatial orchestration. Molecular cancer research : MCR (2023)
Franziska Buescheck, Maciej Zub, Asmus Heumann, Claudia Hube-Magg, Ronald Simon, Dagmar S Lang, Doris Höflmayer, Emily Neubauer, Frank Jacobsen, Andrea Hinsch, Andreas M Luebke, Maria Christina Tsourlakis, Guido Sauter, Hartwig Huland, Markus Graefen, Alexander Haese, Hans Heinzer, Torsten Schlomm, Till S Clauditz, Eike Burandt, Waldemar Wilczak, Stefan Steurer, Sarah Minner
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 41 (7) (2019)